v3.25.4
Significant judgments and sources of estimation uncertainties (Tables)
12 Months Ended
Dec. 31, 2025
Significant judgments and sources of estimation uncertainties  
Schedule of goodwill recognized and impairment analysis

​

​

​

​

​

​

​

​

​

​

​

​

Goodwill recognized

​

​

​

​

​

​

​

​

​

​

in € K

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

December 31, 2025

  ​ ​ ​

October 1, 2025

  ​ ​ ​

June 1, 2025(1)

  ​ ​ ​

December 31, 2024

  ​ ​ ​

October 1, 2024

Goodwill

 

13,571,394

 

13,585,362

 

14,035,273

 

15,170,652

 

14,227,152

thereof Care Delivery

 

11,212,997

 

11,227,831

 

11,613,650

 

13,014,925

 

12,171,616

thereof Value-Based Care

 

368,663

 

368,945

 

382,025

 

n.a.

 

n.a.

thereof Care Enablement

 

1,989,734

 

1,988,586

 

2,039,598

 

2,155,727

 

2,055,536

​

​

​

​

​

​

​

​

​

​

​

​

Excess of recoverable amount over carrying amount

​

​

​

​

​

​

​

​

​

​

in € K

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

December 31, 2025

  ​ ​ ​

October 1, 2025

  ​ ​ ​

June 1, 2025(1)

  ​ ​ ​

December 31, 2024

  ​ ​ ​

October 1, 2024

Care Delivery

 

6,521,602

 

5,606,349

 

5,110,313

 

6,757,218

 

7,454,490

Value-Based Care

 

172,260

 

89,670

 

424,898

 

n.a.

 

n.a.

Care Enablement

 

2,732,309

 

2,672,471

 

8,661,306

 

3,290,699

 

3,360,527

​

​

​

​

​

​

​

​

​

​

​

​

Key assumptions

in %

​

​

​

​

Care Delivery

​

​

December 31, 

​

October 1,

​

June 1,

​

December 31, 

​

October 1,

​

  ​ ​ ​

2025

  ​ ​ ​

2025

  ​ ​ ​

2025(1)

​

2024

  ​ ​ ​

2024

Average revenue growth in projection period

 

low-single-digit

 

low-single-digit

 

low-single-digit

​

mid-single-digit

 

mid-single-digit

Average operating income growth in projection period

​

mid-single-digit

​

mid-single-digit

​

low-single-digit

​

mid-single-digit

​

mid-single-digit

Residual value growth

 

1.00

 

1.00

 

1.00

​

1.00

 

1.00

Pre-tax WACC

 

8.90

​

9.09

 

9.06

​

8.55

 

8.50

After-tax WACC

 

7.21

 

7.39

 

7.37

​

6.46

 

6.45

​

​

​

​

​

​

​

​

​

​

​

Sensitivity analysis

​

​

​

​

​

​

​

​

​

​

Change in percentage points

​

​

​

​

​

​

​

​

​

​

Pre-tax WACC

​

2.69

​

2.36

​

2.18

​

2.46

​

2.77

After-tax WACC

​

2.11

​

1.86

​

1.51

​

1.80

​

2.05

Residual value growth

​

(8.53)

​

(7.40)

​

(6.83)

​

(7.55)

​

(9.37)

Operating income margin of each projection year

​

(3.18)

​

(2.88)

​

(2.39)

​

(2.86)

​

(3.20)

​

​

​

​

​

​

​

​

Key assumptions

in %

​

​

​

​

Value-Based Care

​

  ​ ​ ​

December 31, 2025

  ​ ​ ​

October 1, 2025

  ​ ​ ​

June 1, 2025(1)

Average revenue growth in projection period

​

high-single-digit

​

high-single-digit

​

low-double-digit

Average operating income growth in projection period

​

low-triple-digit

​

low-triple-digit

​

low-triple-digit

Residual value growth

​

2.80

​

2.80

​

2.80

Pre-tax WACC

​

8.53

​

9.00

​

9.45

After-tax WACC

​

7.20

​

7.57

​

7.97

​

​

​

​

​

​

​

Sensitivity analysis

​

​

​

​

​

​

Change in percentage points

​

​

​

​

​

​

Pre-tax WACC

 

1.71

 

0.97

 

6.07

After-tax WACC

 

1.32

 

0.75

 

4.67

Residual value growth

 

(2.36)

 

(1.32)

 

(11.17)

Operating income margin of each projection year

 

(0.41)

 

(0.24)

 

(0.99)

​

​

​

​

​

​

​

​

​

​

​

​

Key assumptions

in %

​

​

​

​

​

​

​

​

Care Enablement

​

​

December 31, 

​

October 1,

​

June 1,

​

December 31, 

​

October 1,

​

  ​ ​ ​

2025

  ​ ​ ​

2025

  ​ ​ ​

2025(1)

  ​ ​ ​

2024

  ​ ​ ​

2024

Average revenue growth in projection period

​

mid-single-digit

​

mid-single-digit

​

mid-single-digit

​

mid-single-digit

​

mid-single-digit

Average operating income growth in projection period

​

high-single-digit

​

high-single-digit

​

high-single-digit

​

low-double-digit

​

low-double-digit

Residual value growth

​

1.00

​

1.00

​

1.00

​

1.00

​

1.00

Pre-tax WACC

​

8.43

(3)  

8.52

(3)  

5.85

(2)  

7.78

​

7.79

After-tax WACC

​

6.42

(3)  

6.51

(3)  

4.6

(2)  

6.00

​

6.03

​

​

​

​

​

​

​

​

​

​

​

Sensitivity analysis

​

​

​

​

​

​

​

​

​

​

Change in percentage points

​

​

​

​

​

​

​

​

​

​

Pre-tax WACC

 

2.02

 

2.01

​

4.35

​

2.30

​

2.39

After-tax WACC

 

1.41

 

1.42

​

3.05

​

1.67

​

1.75

Residual value growth

​

(4.74)

​

(4.84)

​

(13.02)

​

(5.70)

​

(6.16)

Operating income margin of each projection year

 

(2.62)

 

(2.64)

​

(5.24)

​

(2.90)

​

(3.02)

(1)Information as of June 1, 2025 is presented in alignment with the aforementioned changes in the Company’s operating segments. The Company performed an impairment analysis at the date of the reallocation in both the current and prior CGU structure, neither of which indicated any impairment in our operating segments. The key assumptions and sensitivities under both the current and prior CGU structures are not materially different.
(2)The decrease of the after-tax and pre-tax WACC of Care Enablement compared to the status as of December 31, 2024 was mainly driven by a lower beta factor due to peer group changes and lower beta factors of the majority of the remaining peer entities.
(3)The increase of the after-tax and pre-tax WACC of Care Enablement compared to the status as of June 1, 2025 was mainly driven by a refined methodology of WACC calculation in regards to country risk premiums.

​

Schedule of the composition of trade accounts and other receivables from unrelated parties

​

​

​

​

​

​

Composition of trade accounts and other receivables from unrelated parties in %

​

​

December 31, 

​

  ​ ​ ​

2025

  ​ ​ ​

2024

​

​

​

​

​

U.S. Government healthcare programs

 

33

​

34

U.S. commercial payors

 

17

​

18

U.S. hospitals

 

5

​

4

Self-pay of U.S. patients

 

3

​

2

Other U.S. payors

 

1

​

1

Product customers and healthcare payors outside U.S.

 

41

​

41

Total

 

100

​

100

​